Axsome Therapeutics AXSM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$188.3M+32.3% | -$183.17M+36.2% | -$229.53M+26.2% | -$246.9M+20.0% | -$278.27M+6.1% | ||
| $470K-14.4% | $503K-5.5% | $518K-3.4% | $529K-2.2% | $549K+9.6% | ||
| $93.88M+6.3% | $93.75M+10.0% | $93.01M+13.2% | $91.57M+21.6% | $88.34M+26.4% | ||
| -$71.78M+39.3% | -$94.45M+26.4% | -$102M+23.1% | -$120.63M+28.0% | -$118.32M+38.6% | ||
| $263K-48.4% | $480K+77.8% | $439K+77.7% | $471K-10.8% | $510K-16.3% | ||
| -$263K+48.4% | -$480K-77.8% | -$439K-77.7% | -$471K+10.8% | -$510K+16.3% | ||
| —— | —— | —— | —— | —— | ||
| $75.19M-14.8% | $101.47M+75.4% | $99.32M+128% | $108.46M+133% | $88.3M-68.3% | ||
| —— | —— | —— | —— | —— | ||
| -$71.98M+39.4% | -$94.87M+26.3% | -$102.38M+22.9% | -$121.1M+27.9% | -$118.83M+38.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Axsome Therapeutics generate?
- Axsome Therapeutics (AXSM) generated -$71.8M in operating cash flow over the trailing twelve months.
- What is Axsome Therapeutics's free cash flow?
- After $263.0K of capital expenditures, Axsome Therapeutics's free cash flow was -$72.0M over the trailing twelve months, up 39.4% year over year.
- Where does Axsome Therapeutics's cash flow data come from?
- Every line is extracted from Axsome Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
